| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3830451
[patent_doc_number] => 05712085
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-27
[patent_title] => '5\'-(4-amino-2-oxa)butye-4,4\', 8-trinethylpsoralen in synthetic medium'
[patent_app_type] => 1
[patent_app_number] => 8/465148
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 43
[patent_no_of_words] => 33672
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/712/05712085.pdf
[firstpage_image] =>[orig_patent_app_number] => 465148
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465148 | 5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium | Jun 4, 1995 | Issued |
| 08/465545 | TREATING RED BLOOD CELL SOLUTIONS WITH ANTI-VIRAL AGENTS | Jun 4, 1995 | Abandoned |
Array
(
[id] => 3619418
[patent_doc_number] => 05688672
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Process for the biotechnological preparation of L-thienylalanines in enantiomerically pure form from 2-hydroxy-3-thienylacrylic acids'
[patent_app_type] => 1
[patent_app_number] => 8/460873
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8275
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/688/05688672.pdf
[firstpage_image] =>[orig_patent_app_number] => 460873
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460873 | Process for the biotechnological preparation of L-thienylalanines in enantiomerically pure form from 2-hydroxy-3-thienylacrylic acids | Jun 4, 1995 | Issued |
Array
(
[id] => 3581059
[patent_doc_number] => 05580783
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-03
[patent_title] => 'Enzymatic process for the preparation of chiral .alpha.-tertiary carboxylic acid esters'
[patent_app_type] => 1
[patent_app_number] => 8/457891
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5847
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/580/05580783.pdf
[firstpage_image] =>[orig_patent_app_number] => 457891
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457891 | Enzymatic process for the preparation of chiral .alpha.-tertiary carboxylic acid esters | May 31, 1995 | Issued |
Array
(
[id] => 3780393
[patent_doc_number] => 05821045
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-13
[patent_title] => 'Methods for removal of cryoprotectant from organs prior to transplantation'
[patent_app_type] => 1
[patent_app_number] => 8/455027
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 43
[patent_no_of_words] => 27067
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/821/05821045.pdf
[firstpage_image] =>[orig_patent_app_number] => 455027
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/455027 | Methods for removal of cryoprotectant from organs prior to transplantation | May 30, 1995 | Issued |
Array
(
[id] => 3585760
[patent_doc_number] => 05552317
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Method for preparing optically active homophenylalanine and esters thereof using lipase from wheat germ or Candida lipolytica'
[patent_app_type] => 1
[patent_app_number] => 8/451602
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4049
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552317.pdf
[firstpage_image] =>[orig_patent_app_number] => 451602
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451602 | Method for preparing optically active homophenylalanine and esters thereof using lipase from wheat germ or Candida lipolytica | May 25, 1995 | Issued |
Array
(
[id] => 3585774
[patent_doc_number] => 05552318
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Method for preparing optically active amino acids and their esters using wheat germ lipase'
[patent_app_type] => 1
[patent_app_number] => 8/451631
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6289
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552318.pdf
[firstpage_image] =>[orig_patent_app_number] => 451631
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451631 | Method for preparing optically active amino acids and their esters using wheat germ lipase | May 25, 1995 | Issued |
Array
(
[id] => 3724439
[patent_doc_number] => 05700656
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-23
[patent_title] => 'Silver stain for collagen matrix from paraffin embedded tissue'
[patent_app_type] => 1
[patent_app_number] => 8/449910
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1934
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/700/05700656.pdf
[firstpage_image] =>[orig_patent_app_number] => 449910
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449910 | Silver stain for collagen matrix from paraffin embedded tissue | May 24, 1995 | Issued |
Array
(
[id] => 3743601
[patent_doc_number] => 05716777
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-10
[patent_title] => 'Regulation of meiosis using sterols'
[patent_app_type] => 1
[patent_app_number] => 8/448217
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7336
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 322
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/716/05716777.pdf
[firstpage_image] =>[orig_patent_app_number] => 448217
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/448217 | Regulation of meiosis using sterols | May 22, 1995 | Issued |
Array
(
[id] => 3883458
[patent_doc_number] => 05776747
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer'
[patent_app_type] => 1
[patent_app_number] => 8/447778
[patent_app_country] => US
[patent_app_date] => 1995-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 18023
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776747.pdf
[firstpage_image] =>[orig_patent_app_number] => 447778
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/447778 | Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer | May 22, 1995 | Issued |
Array
(
[id] => 3632099
[patent_doc_number] => 05610039
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-11
[patent_title] => 'Process for producing N-substituted-1-deoxynojirimycin'
[patent_app_type] => 1
[patent_app_number] => 8/444505
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10253
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/610/05610039.pdf
[firstpage_image] =>[orig_patent_app_number] => 444505
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444505 | Process for producing N-substituted-1-deoxynojirimycin | May 18, 1995 | Issued |
Array
(
[id] => 3621713
[patent_doc_number] => 05602013
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-02-11
[patent_title] => 'Process for producing N-substituted-1-deoxynojirimycin'
[patent_app_type] => 1
[patent_app_number] => 8/444636
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10239
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/602/05602013.pdf
[firstpage_image] =>[orig_patent_app_number] => 444636
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444636 | Process for producing N-substituted-1-deoxynojirimycin | May 18, 1995 | Issued |
Array
(
[id] => 3685363
[patent_doc_number] => 05643712
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-01
[patent_title] => 'Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix coating'
[patent_app_type] => 1
[patent_app_number] => 8/437155
[patent_app_country] => US
[patent_app_date] => 1995-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8220
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/643/05643712.pdf
[firstpage_image] =>[orig_patent_app_number] => 437155
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/437155 | Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix coating | May 16, 1995 | Issued |
Array
(
[id] => 3586870
[patent_doc_number] => 05516662
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-14
[patent_title] => 'Process for the preparation of headgroup-modified phospholipids using phosphatidylhydroxyalkanols as intermediates'
[patent_app_type] => 1
[patent_app_number] => 8/439074
[patent_app_country] => US
[patent_app_date] => 1995-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5106
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/516/05516662.pdf
[firstpage_image] =>[orig_patent_app_number] => 439074
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439074 | Process for the preparation of headgroup-modified phospholipids using phosphatidylhydroxyalkanols as intermediates | May 10, 1995 | Issued |
Array
(
[id] => 3574132
[patent_doc_number] => 05523233
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-04
[patent_title] => 'Enzymatic hydrolysis of 3,3-diethyl-4-[(4-carboxy)phenoxy]-2-azetidinone esters'
[patent_app_type] => 1
[patent_app_number] => 8/433586
[patent_app_country] => US
[patent_app_date] => 1995-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2885
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/523/05523233.pdf
[firstpage_image] =>[orig_patent_app_number] => 433586
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/433586 | Enzymatic hydrolysis of 3,3-diethyl-4-[(4-carboxy)phenoxy]-2-azetidinone esters | May 2, 1995 | Issued |
| 08/432842 | INDUCEMENT OF THERMOTOLERANCE WITH BENZOQUINONOID ANSAMYCINS | May 1, 1995 | Abandoned |
Array
(
[id] => 3552110
[patent_doc_number] => 05573949
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-11-12
[patent_title] => 'Enzymatic process for the preparation of optically active Tetrahydro-2-naphthoic acids'
[patent_app_type] => 1
[patent_app_number] => 8/425743
[patent_app_country] => US
[patent_app_date] => 1995-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7622
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/573/05573949.pdf
[firstpage_image] =>[orig_patent_app_number] => 425743
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/425743 | Enzymatic process for the preparation of optically active Tetrahydro-2-naphthoic acids | Apr 19, 1995 | Issued |
| 08/424895 | METHOD FOR THE MICROBIAL DECONTAMINATION OF BLOOD PLATELETS | Apr 18, 1995 | Abandoned |
Array
(
[id] => 3549213
[patent_doc_number] => 05547857
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-20
[patent_title] => 'Process for producing 5-methyluridine and purification by sedimentation velocity'
[patent_app_type] => 1
[patent_app_number] => 8/422946
[patent_app_country] => US
[patent_app_date] => 1995-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4721
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/547/05547857.pdf
[firstpage_image] =>[orig_patent_app_number] => 422946
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/422946 | Process for producing 5-methyluridine and purification by sedimentation velocity | Apr 16, 1995 | Issued |
Array
(
[id] => 3655632
[patent_doc_number] => 05622855
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-22
[patent_title] => 'Preserved, non-infectious control cells prepared by the modulation or modification of cultured cells'
[patent_app_type] => 1
[patent_app_number] => 8/378840
[patent_app_country] => US
[patent_app_date] => 1995-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 5911
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/622/05622855.pdf
[firstpage_image] =>[orig_patent_app_number] => 378840
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/378840 | Preserved, non-infectious control cells prepared by the modulation or modification of cultured cells | Apr 9, 1995 | Issued |